SCHEMBL542353

SCHEMBL542353

CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@H](CO)[C@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAG P20916 1/20 0.58
▸ LGALS3 P17931 5/20 0.54
▸ LGALS8 O00214 2/20 0.54
▸ LGALS4 P56470 1/20 0.54
▸ SLC6A2 P23975 1/20 0.53
▸ FGF1 P05230 1/20 0.51
▸ FGF2 P09038 1/20 0.51
▸ VEGFA P15692 1/20 0.51
▸ HPSE Q9Y251 1/20 0.51
▸ LGALS7; LGALS7B P47929 2/20 0.50
▸ LGALS1 P09382 1/20 0.50
▸ HRAS P01112 1/20 0.49
▸ POLB P06746 1/20 0.48
▸ LGALS9 O00182 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL542355 1.00 MAG (0.58) MAGLGALS3LGALS8LGALS4SLC6A2
SCHEMBL7717946 1.00 MAG (0.58) MAGLGALS3LGALS8LGALS4SLC6A2
SCHEMBL7717956 1.00 MAG (0.58) MAGLGALS3LGALS8LGALS4SLC6A2
SCHEMBL16153923 1.00 MAG (0.58) MAGLGALS3LGALS8LGALS4SLC6A2
SCHEMBL29859879 0.94 MAG (0.55) MAGLGALS3LGALS8LGALS4SLC6A2
SCHEMBL5841006 0.91 MAG (0.55) MAGLGALS3LGALS8SLC6A2HRAS
SCHEMBL5841546 0.91 MAG (0.55) MAGLGALS3LGALS8SLC6A2HRAS
SCHEMBL22204678 0.91 MAG (0.55) MAGLGALS3LGALS8SLC6A2HRAS
SCHEMBL5841001 0.91 MAG (0.55) MAGLGALS3LGALS8SLC6A2HRAS
SCHEMBL4275701 0.91 MAG (0.54) MAGLGALS3LGALS8SLC6A2LGALS7; LGALS7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1543165-B1 ASSAYS FOR ASSEMBLY OF EBOLA VIRUS NUCLEOCAPSIDS US GOV HEALTH & HUMAN SERV (US) 2012-02-08 — — EP disclosed
US-7449190-B2 Assays for assembly of Ebola virus nucleocapsids THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2008-11-11 — — US disclosed
EP-1543165-A4 ASSAYS FOR ASSEMBLY OF EBOLA VIRUS NUCLEOCAPSIDS US GOV HEALTH & HUMAN SERV (US) 2007-05-09 — — EP disclosed
US-20050180993-A1 Assays for assembly of ebola virus nucleocapsids HEALTH AND HUMAN SERVICES, GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF 2005-08-18 — — US disclosed
EP-1543165-A2 ASSAYS FOR ASSEMBLY OF EBOLA VIRUS NUCLEOCAPSIDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, the Department of Health and Human Services, (US) 2005-06-22 — — EP disclosed
WO-2004007747-A2 ASSAYS FOR ASSEMBLY OF EBOLA VIRUS NUCLEOCAPSIDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2004-01-22 — — WO disclosed
US-20020142046-A1 Protein particles for therapeutic and diagnostic use YEN, RICHARD C.K. 2002-10-03 — — US disclosed
US-6391343-B1 PARTICLE COMPRISING FIBRINOGEN BOUND ON SURFACE OF ALBUMIN MATRIX, CAPABLE OF CO-AGGREGATION WITH PLATELETS, AND OF AGGREGATION IN SOLUTION CONTAINING SOLUBLE FIBRINOGEN AT CONCENTRATION NOT CAPABLE OF CLOT FORMATION BY ITSELF HEMOSPHERE, INC. 2002-05-21 — — US disclosed
US-5945033-A ALBUMIN, HEMOGLOBIN MIXTURE; STABILITY HEMOSPHERE, INC. (US) 1999-08-31 — — US disclosed
US-5725804-A ALBUMIN PARTICLES STABLE TO RESOLUBILIZATION, POLYOXYETHYLENE GLYCOL, ALCOHOL HEMOSPHERE, INC. (US) 1998-03-10 — — US disclosed
EP-0439585-B1 IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS MAG GEORG MAYRHOFER & CO OHG (AT) 1997-10-29 — — EP disclosed
US-5616311-A AQUEOUS ALBUMIN SUSPENSION STABILIZED BY HEMOGLOBIN PARTICLES HEMOSPHERE, INC. (US) 1997-04-01 — — US disclosed
Send feedback